MCKESSON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 543.3 USD | +0.62% |
|
+3.52% | +17.35% |
| 24/04 | McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3 | MT |
| 24/04 | McKesson Corporation Declares Quarterly Dividend, Payable on June 3, 2024 | CI |
| Sales 2024 * | 312B 26,007B | Sales 2025 * | 338B 28,154B | Capitalization | 71.39B 5,953B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.03B 253B | Net income 2025 * | 3.52B 294B | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 1.78B 149B | Net Debt 2025 * | 478M 39.87B | EV / Sales 2025 * | 0.21 x |
| P/E ratio 2024 * |
24.7
x | P/E ratio 2025 * |
19.6
x | Employees | 48,000 |
| Yield 2024 * |
0.44% | Yield 2025 * |
0.51% | Free-Float | 46.58% |
More Fundamentals
* Assessed data
More news
Latest transcript on McKesson Corporation
More recommendations
More press releases
| 1 day | +0.62% | ||
| 1 week | +3.52% | ||
| Current month | +1.20% | ||
| 1 month | +0.75% | ||
| 3 months | +11.96% | ||
| 6 months | +21.26% | ||
| Current year | +17.35% |
1 week
517.82
544.81
1 month
514.88544.81
Current year
462.70544.81
1 year
352.34544.81
3 years
180.42544.81
5 years
112.60544.81
10 years
106.11544.81
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 57 | 01/12/01 |
| Director of Finance/CFO | 55 | 27/18/27 | |
Francisco Fraga
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Donald Knauss
CHM | Chairman | 73 | 20/14/20 |
Webster Dunbar
BRD | Director/Board Member | 62 | 01/22/01 |
| Director/Board Member | 66 | 13/22/13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.31% | 1,026 M€ | +6.95% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 543.3 | +0.62% | 654,669 |
| 25/24/25 | 539.9 | +0.84% | 635,557 |
| 24/24/24 | 535.4 | +0.64% | 583,497 |
| 23/24/23 | 532 | +0.89% | 490,789 |
| 22/24/22 | 527.3 | +0.47% | 893,497 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
08/05/2024
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
543.3
USD
Average target price
559.5
USD
Spread / Average Target
+2.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- MCK Stock
